Detalle de: Fungemia with Saccharomyces cerevisiae in Two Newborns, Only One of Whom Had Been Treated with Ultra-Levura
| Title | Fungemia with Saccharomyces cerevisiae in Two Newborns, Only One of Whom Had Been Treated with Ultra-Levura |
| Abstract |
Ultra-Levura (Upsamedica, Spain) is a yeast (Saccharomyces boulardii) widely used as a biotherapeutic agent. To date, few adverse effects have been reported, although fungemia with Saccharomyces cerevisiae can occur in weak and immunosuppressed patients. Reported here are two cases of fungemia with Saccharomyces cerevisiae. One patient had been treated with Ultra-Levura and the other contracted the infection from the first. This is the first report of infection with Saccharomyces boulardii (Saccharomyces cerevisiae) in a patient who was not being treated with the agent. |
| Apa Reference | Perapoch, J., Planes, A.M., Querol, A., L�pez, V., Mart�nez-Benday�n, I., Tormo, R., Fern�ndez, F., Peguero, G. & Salcedo, S. (2000). Fungemia with Saccharomyces cerevisiae in Two Newborns, Only One of Whom Had Been Treated with Ultra-Levura. European Journal of Clinical Microbiology & Infectious Diseases, 19(6), 468-470. 10.1007/s100960000295 |
| Doi | 10.1007/s100960000295 |
| Publication Date | 4 Jul 2000 |
| Publication Type | Article |
| Researcher | Amparo Querol |
| Ontology | Model organisms |
| Research Groups | |
| Tools |